Warning! GuruFocus detected
1 Severe warning sign
with CELC.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Celcuity Inc
NAICS : 541714
SIC : 2834
ISIN : US15102K1007
Compare
Compare
Traded in other countries / regions
CELC.USA Index Membership
Russell 2000Russell 3000Russell 2000 IPO Date
2017-09-20Description
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.4 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.85 | |||||
| Debt-to-EBITDA | -0.97 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -7 | |||||
| 3-Year EPS without NRI Growth Rate | -8.6 | |||||
| 3-Year FCF Growth Rate | -11.7 | |||||
| 3-Year Book Growth Rate | -12.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 28.03 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.94 | |||||
| 9-Day RSI | 26.45 | |||||
| 14-Day RSI | 32.91 | |||||
| 3-1 Month Momentum % | -34.65 | |||||
| 6-1 Month Momentum % | -39.95 | |||||
| 12-1 Month Momentum % | -55.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.71 | |||||
| Quick Ratio | 7.71 | |||||
| Cash Ratio | 7.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35.5 | |||||
| Shareholder Yield % | -31.99 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -78.11 | |||||
| ROA % | -46.96 | |||||
| ROIC % | -5746.09 | |||||
| 3-Year ROIIC % | -2363.23 | |||||
| ROC (Joel Greenblatt) % | -16628.28 | |||||
| ROCE % | -46.92 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.65 | |||||
| Price-to-Tangible-Book | 2.65 | |||||
| EV-to-EBIT | -1.93 | |||||
| EV-to-EBITDA | -1.93 | |||||
| EV-to-FCF | -2.51 | |||||
| Price-to-Net-Current-Asset-Value | 2.65 | |||||
| Price-to-Net-Cash | 2.9 | |||||
| Earnings Yield (Greenblatt) % | -51.81 | |||||
| FCF Yield % | -26.88 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CELC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Celcuity Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.81 | ||
| Beta | -0.53 | ||
| 3-Year Sharpe Ratio | 0.2 | ||
| 3-Year Sortino Ratio | 0.35 | ||
| Volatility % | 42.35 | ||
| 14-Day RSI | 32.91 | ||
| 14-Day ATR ($) | 0.812068 | ||
| 20-Day SMA ($) | 10.2095 | ||
| 12-1 Month Momentum % | -55.5 | ||
| 52-Week Range ($) | 8.07 - 20.885 | ||
| Shares Outstanding (Mil) | 37.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Celcuity Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Celcuity Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Celcuity Inc Frequently Asked Questions
What is Celcuity Inc(CELC)'s stock price today?
The current price of CELC is $8.23. The 52 week high of CELC is $20.89 and 52 week low is $8.07.
When is next earnings date of Celcuity Inc(CELC)?
The next earnings date of Celcuity Inc(CELC) is 2025-05-15 Est..
Does Celcuity Inc(CELC) pay dividends? If so, how much?
Celcuity Inc(CELC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers